Martha French
Keine laufenden Positionen mehr
Profil
Martha French worked as a Vice President at Lark Technologies, Inc. from 1989 to 1994.
She then worked as a Director of Regulatory Affairs at InGeneron, Inc. from 2009 to 2011.
From 2011 to 2019, she worked as a Vice President of Regulatory Affairs at Bellicum Pharmaceuticals, Inc. Ms. French received an undergraduate degree from Carroll University, Inc.
Ehemalige bekannte Positionen von Martha French
| Unternehmen | Position | Ende |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | General Counsel | 01.05.2019 |
InGeneron, Inc.
 InGeneron, Inc. Miscellaneous Commercial ServicesCommercial Services InGeneron, Inc. engages in the provision of cell-based technologies for health care and life science research. The company was founded in 2006 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.11.2011 |
Lark Technologies, Inc.
 Lark Technologies, Inc. Computer CommunicationsElectronic Technology LARK Technologies, Inc. provided compelling solutions for better sleep. It also offered weight loss services. The company was founded by Julia Hu and Jeff Zira in 2010 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.01.1994 |
Ausbildung von Martha French
| Carroll University, Inc. | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Lark Technologies, Inc.
Lark Technologies, Inc. Computer CommunicationsElectronic Technology LARK Technologies, Inc. provided compelling solutions for better sleep. It also offered weight loss services. The company was founded by Julia Hu and Jeff Zira in 2010 and is headquartered in Houston, TX. | Electronic Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
InGeneron, Inc.
InGeneron, Inc. Miscellaneous Commercial ServicesCommercial Services InGeneron, Inc. engages in the provision of cell-based technologies for health care and life science research. The company was founded in 2006 and is headquartered in Houston, TX. | Commercial Services |
